Aug 21 (Reuters) - Xtek Ltd (XTE) : RECONFIRMS FY19 REVENUE GUIDANCE OF BETWEEN A$17 MILLION AND A$26M FY18 REVENUE A$17.2MLN, UP 91% RECONFIRMS FY19 REVENUE GUIDANCE OF BETWEEN A$17 AND A$26M
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025